The Integrated Medical Model: Statistical Forecasting of Risks to Crew Health and Mission Success by Butler, D. J. et al.
IMM Output - Examples
The IMM currently models 37 disorders, however only a few conditions have 
assigned diagnosis and treatment protocols so the following forecasts are offered 
as examples only.  Each forecast represents 10,000 mission simulations, with one 
male and one female crew member (two crew total).
• Insomnia
• Headache – space adaptation
• Nasal Congestion
• Space Motion Sickness
• Constipation
• Diarrhea
• Indigestion
• Abdominal Cramping
• Nosebleed (epistaxis)
• Urinary Retention
• Urinary Incontinence
• Urinary Tract Infection
• Skin Rash
• Skin Infection
• Mouth Ulcer
• Burn
• Dental Issues
• Dislocation – finger
• etc.
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Summary
The IMM will continue to add conditions and refine the clinical evidence base, and 
is on track to help support risk-based decisions for medical systems and 
operational concepts for the Constellation Program. The IMM Project coordinates 
data mining and modeling activities with other Risk Management efforts such as 
the Exploration Medicine Element, Risk Assessment and Integration Team (RAIT), 
SD2/Delphi Study, and Longitudinal Study of Astronaut Health (LSAH) Office.
Overview
The Integrated Medical Model (IMM) helps capture and use organizational knowledge 
across the space medicine, training, operations, engineering, and research domains.  
The IMM uses this domain knowledge in the context of a mission and crew profile to 
forecast crew health and mission success risks.  The IMM is most helpful in comparing 
the risk of two or more mission profiles, not as a tool for predicting absolute risk.   The 
process of building the IMM adheres to Probability Risk Assessment (PRA) techniques 
described in NASA  Procedural Requirement (NPR) 8705.5, and uses current evidence-
based information to establish a defensible position for making decisions that help 
ensure crew health and mission success.  The IMM quantitatively describes the following 
input parameters:
• medical conditions and likelihood,
• mission duration,
• vehicle environment, 
• crew attributes (e.g. age, sex) 
• crew activities (e.g. EVA’s, Lunar excursions),
• diagnosis and treatment protocols (e.g. medical equipment, consumables 
pharmaceuticals), and
• Crew Medical Officer (CMO) training effectiveness.
It is worth reiterating that the IMM uses the data sets above as inputs.  Many other risk 
management efforts stop at determining only likelihood.  The IMM is unique in that it 
models not only likelihood, but risk mitigations, as well as subsequent clinical 
outcomes based on those mitigations. Once the mathematical relationships among 
the above parameters are established, the IMM uses a Monte Carlo simulation technique 
(a random sampling of the inputs as described by their statistical distribution) to 
determine the probable outcomes.  Because the IMM is a stochastic model (i.e. the input 
parameters are represented by various statistical distributions depending on the data 
type), when the “mission” is simulated 10-50,000 times with a given set of medical 
capabilities (risk mitigations), a prediction of the most probable outcomes can be 
generated.  For each “mission”, the IMM tracks which conditions occurred and 
decrements the pharmaceuticals and supplies required to diagnose and treat these 
medical conditions.  If supplies are depleted, then the medical condition goes untreated, 
and crew and mission risk increase.  The IMM currently models approximately 30 
medical conditions.  By the end of FY2008, the IMM will be modeling over 100 medical 
conditions, approximately 60 of which have been recorded to have occurred during short 
and long space missions. 
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Methods
 Establishing a List of Relevant Medical Conditions – A baseline list of medical conditions 
serves as the IMM clinical modelling roadmap and is required to manage the scope of the project.  
The current Baseline List of Medical Conditions (BLMC) – derived from the ISS Medical Checklist 
- covers approximately 75 conditions, most of which have occurred during past space flights.  The 
ISS Checklist was used as a starting point; the BLMC will be supplemented with new data from 
the Longitudinal Study of Astronaut Health (LSAH) Database, Delphi Study, and space medicine 
peer reviews. 
 Establishing incidence rates – The IMM incidence rate (defined as events/person-year) for each 
condition on the BLMC was initially established from reviewing historical medical event records 
from the Apollo, Skylab, Shuttle, Mir, and ISS Programs.  Additional incidence data was derived 
by conducting brief literature reviews and queries to the LSAH Database.  The in-flight incidence 
data will be updated with terrestrial surrogate population data as applicable; a collaboration with 
the United States Army Aeromedical Research Laboratory is underway.
 To gain greater insight of operations or risk factors, some medical conditions such as bone 
fracture, renal stone formation, behavioural health have stochastic predictive models developed 
to forecast incidence rates.  These forecasted distributions are then used in the IMM as inputs.
 Clinical Findings Form (CliFF); Quantifying clinical information for each condition - The 
CliFF serves as both a clinical requirements document (for the development of the IMM) and 
reference document for each medical condition modeled in the IMM.  The CliFF provides a 
framework for the clinician to capture clinical and operational data in a quantified form needed by 
the IMM.  The quantified data (either deterministic or stochastic), assumptions, and sourced 
references provide a defensible position for accepting risk and making financial investments in 
areas where little information exists.  The table below is an excerpt from the CliFF for corneal 
abrasion:
 Resource Table; Quantifying the items needed to diagnose and treat each condition – For 
each medical condition, the tasks and items needed to diagnose and treat the disorder are 
recorded.  For each medical item, the quantity required, unit mass, and unit volume are tracked for 
both a best-case and worse-case treatment scenario.  Eventually, tasks and items required to 
provide the best urban care will be included in the IMM to enable comparisons with terrestrial 
standards and establish a metric for clinical effectiveness.
 Establishing Metrics for Crew Health Risk – Adopted from AMA guidelines, the Quality 
Adjusted Life Years (QALY) lost metric accounts for the final functional impairment of the 
individual based on available mitigation strategies and life expectancy.  All things equal, health 
risks (a.k.a. QALY lost) will be greater for younger individuals since they have more quality years 
to lose due to their longer life expectancy.
 Establishing Metrics for Mission Risk resulting from crew health disorders – Mission risk is 
done by scaling the lost QALY’s  to the duration of the mission instead of expected life span.
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The IMM user interface is Excel with the added statistical 
forecasting and optimization functionality provided by Crystal 
Ball.  Crew, mission, and all other medical modeling occur here.
A VBA interface module acts as the interface between the 
Resource Manager and Excel.  A built in Test Macro 
ensures the IMM and Resource Manager are exchanging 
data as intended. 
The Resource Manager tracks the medical consumables needed 
to diagnosis and treat each condition.  If all the consumables 
have been used (or were not flown for that mission), the medical
condition goes untreated.  After each Monte Carlo simulation 
(aka “mission run”), the RM resets for the next “mission”.
Each medical condition modeled in the IMM is mapped to the 
medical resources (unit mass, unit volume, and quantity) 
required to diagnose and treat that condition.  Eventually unit 
cost will be added to the Resource database to facilitate trade 
studies among medical risk, cost, mass, and volume.
Validation
 Clinical – Clinical validation is a multi-tiered, continuous effort.  Data is initially 
vetted by the IMM Clinical Lead, then reviewed by Space Medicine Subject 
Matter Advisors, and finally Independent Clinical Reviewers. This validation 
process would also assess the accuracy of the tasks and resources required to 
diagnose and treat each condition.
 Statistical – Statistical validation is currently a three-phased effort. Phase I 
ensures the correct distributions have been assigned to all model assumptions.  
Phase II tests the model with extreme values.  And Phase III compares 
predicted forecasts with empirical data if available.
 Architecture/Design – To ensure the IMM is operating properly, the IMM is 
tested after medical conditions are modelled per the CliFF.  The Clinical Lead 
reviews IMM forecasts and sensitivity analyses to identify and resolve 
inconsistencies early.
Table of Treatments and Outcomes
Diagnosis & Initial 
Treatment
Treatment/ 
Convalescence
Recovered/ Mission 
End State
TREATMENT 
OPTIONS
FI*
(%)
Duration 
(hrs)
FI 
(%)
Duration 
(hrs)
FI 
(%)
Mission 
End state 
results**
ISS-based Treatment
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ISS-based Treatment
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6-Month Mission with no medical 
capabilities.  Since no conditions were 
treated, the actual mission outcome 
(green) is equal to the untreated scenario 
(blue).  Mission Goal Point (red) reflects 
outcomes if resources were unlimited and 
treatments were 100% effective.
6-Month Mission with medical 
capabilities shows a strong shift 
toward a higher probability of 
mission success
Key Assumptions, Inaccuracies
• The IMM views the mission from the point of view of the mission debrief. This 
means the mission is viewed as if it was already completed. What happened 
on which day is not tracked. We experimented with tracking each day and 
building a mission log, but it turned out to be very complex and not very helpful 
at the time. This choice leads to additional limitations.
• All medical events are completely separate. The only exception are recurrent 
disorders that depend on an index case. All outcomes are calculated as if they 
were the only impact on the mission, then summed together. This causes a 
higher QALY lost.
IMM Capabilities
 Simultaneously assesses ALL parameters that influence medical risk in the context of a 
mission and crew profile.  Other risk efforts typically examine one medical condition at 
a time (e.g. by using the 5x5 risk matrix),.
 Evaluates mission risk by modeling all three risk components (likelihood, available 
mitigation strategy, and consequence).  Many risk efforts stop once an estimation of 
likelihood is characterized,
 Uses Monte Carlo simulation to forecast the most likely outcomes for a mission and 
crew profile
 Offers optional optimization of the contents of a crew health care system
 Aids operational and research decisions based on risk, mission or crew attributes, or 
medical system mass and volume
 Provides various analysis capabilities (e.g. sensitivity analyses, spider charts, and 
tornado charts) to identify key contributors that influence clinical outcomes, mission 
success, and enterprise budgets.  By identifying contributors that are most influential to 
risk, organizational resources can be focused on the efforts that matter most
 Accounts for uncertainty in both the model inputs and outputs, and
 Characterizes the level and duration of impairment of a crew member by using a utility 
measure  (i.e. % whole body impairment; also termed “functional impairment) currently 
used by the American Medical Association (AMA) and the medical insurance industry
3-year Mission with medical 
capabilities.  Mission 
Performance clearly shows the 
bimodal distribution associated 
by modelling a worst case and 
best case clinical outcome.
B) Sensitivity analysis reveals nasal 
congestion is the most influential 
variable determining how many 
disorders occur.
A) 6-month Mission forecast 
of total number of medical 
disorders (assuming a 
universe of 37 conditions)
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The Integrated Medical Model (IMM) Project
• Overview – Statistical decision support tool for forecasting crew 
health and related mission risks, and optimizing the medical logistics 
“footprint” of in-flight crew medical systems
• Progress to Date
– Established Baseline list of approximately 75 conditions
– 37 medical conditions modeled
– Defined Risk Metrics for crew and mission
– Established Clinical Finding Form Template
– Developed Resource Manager Software to track medical consumables
– Compiled historical Review of Medical Events
– Populating Resource Tables with unit quantity, mass, and volume 
Collaborating with USAARL to refine incident data with surrogate
population data
– Developing Clinical and Statistical Validations Plans
9 Validated planning tool
∆ Baseline Medical Conditions List  
9 Logistics mapped to risks
∆ Complete CLIFF’s (72+ conditions)  
∆ Model 72+ Conditions  
∆ Integrate Resource Table (72+ conditions x2)  
∆ Assess/Integrate USAARL data  
∆ Establish Statistical/Clincal Validation Plans  
∆ Incorporate Delphi Data (when available)  
∆ Refine Loss of Mission (LOM) metric  
∆ Initiate Statistical/Clinical Validation Plans  
∆ Complete Initial Validation  
∆ Expand Risk Factors
FY2008 FY2009 FY2010 Capabilities
∆ Database Integration
9 Increased crew/mission 
modeling fidelity
9 Efficient, current modeling 
with HITT/PCDB
∆ 120+ conditions modeled 9 Increased confidence levels
9 Baseline conditions list +
9 Refined comparative 
mission risk assessments
9 Efficient, current modeling
9 Baseline conditions list 
expanded via surrogate 
population data
9 Initial roadmap established
9 Outcomes mapped to 
conditions and treatments
9 Initial assessments capable
∆ 100+ conditions modeled (est.)  9 Increased confidence levels
∆ Migrate CliFF’s to database 9 Prep. for database integration
∆ Develop Database Integration Requirements  9 Ensure knowledge capture
IMM Key Milestones
